Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1974 Jan;16(1):77–88.

The role of complement in localized shwartzman reaction: studies with congenitally C6-deficient rabbits.

J S Fong, K O Rother, R A Good
PMCID: PMC1553988  PMID: 4468178

Full text

PDF
77

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biro C. E. The role of the sixth component of complement in some types of hypersensitivity. Immunology. 1966 Jun;10(6):563–565. [PMC free article] [PubMed] [Google Scholar]
  2. DES PREZ R. M., HOROWITZ H. I., HOOK E. W. Effects of bacterial endotoxin on rabbit platelets. I. Platelet aggregation and release of platelet factors in vitro. J Exp Med. 1961 Dec 1;114:857–874. doi: 10.1084/jem.114.6.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fong J. S., Good R. A. Prevention of the localized and generalized Shwartzman reactions by an anticomplementary agent, cobra venom factor. J Exp Med. 1971 Sep 1;134(3 Pt 1):642–655. doi: 10.1084/jem.134.3.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gaynor E., Bouvier C., Spaet T. H. Vascular lesions: possible pathogenetic basis of the generalized Shwartzman reaction. Science. 1970 Nov 27;170(3961):986–988. doi: 10.1126/science.170.3961.986. [DOI] [PubMed] [Google Scholar]
  5. Götze O., Müller-Eberhard H. J. The C3-activator system: an alternate pathway of complement activation. J Exp Med. 1971 Sep 1;134(3 Pt 2):90s–108s. [PubMed] [Google Scholar]
  6. HOROWITZ H. I., DES PREZ R. M., HOOK E. W. Effects of bacterial endotoxin on rabbit platelets. II. Enhancement of platelet factor 3 activity in vitro and in vivo. J Exp Med. 1962 Nov 1;116:619–633. doi: 10.1084/jem.116.5.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Henson P. M., Cochrane C. G. Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement. J Exp Med. 1969 Jan 1;129(1):167–184. doi: 10.1084/jem.129.1.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Johnson K. J., Ward P. A. Protective function of C6 in rabbits treated with bacterial endotoxin. J Immunol. 1971 Apr;106(4):1125–1127. [PubMed] [Google Scholar]
  9. LEE L. Antigen-antibody reaction in the pathogenesis of bilateral renal cortical necrosis. J Exp Med. 1963 Mar 1;117:365–376. doi: 10.1084/jem.117.3.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lerner R. G., Rapaport S. I., Siemsen J. K., Spitzer J. M. Disappearance of fibrinogen-131-I after endotoxin: effects of a first and second injection. Am J Physiol. 1968 Mar;214(3):532–537. doi: 10.1152/ajplegacy.1968.214.3.532. [DOI] [PubMed] [Google Scholar]
  11. McGrath J. M., Stewart G. J. The effects of endotoxin on vascular endothelium. J Exp Med. 1969 May 1;129(5):833–848. doi: 10.1084/jem.129.5.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McKAY D. G., SHAPIRO S. S. Alterations in the blood coagulation system induced by bacterial endotoxin. I. In vivo (generalized Shwartzman reaction). J Exp Med. 1958 Mar 1;107(3):353–367. doi: 10.1084/jem.107.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mergenhagen S. E., Snyderman R., Gewurz H., Shin H. S. Significance of complement to the mechanism of action of endotoxin. Curr Top Microbiol Immunol. 1969;50:37–77. doi: 10.1007/978-3-642-46169-9_2. [DOI] [PubMed] [Google Scholar]
  14. ROTHER K., ROTHER U., SCHINDERA F. PASSIVE ARTHUS-REAKTION BEI KOMPLEMENT-DEFEKTEN KANINCHEN. Z Immunitats Allergieforsch. 1964 Jun;126:473–488. [PubMed] [Google Scholar]
  15. RUBENSTEIN H. S., FINE J., COONS A. H. Localization of endotoxin in the walls of the peripheral vascular system during lethal endotoxemia. Proc Soc Exp Biol Med. 1962 Nov;111:458–467. doi: 10.3181/00379727-111-27824. [DOI] [PubMed] [Google Scholar]
  16. Rodríguez-Erdmann F. Intravascular activation of the clotting system with phospholipids. Production of the generalized Shwartzman reaction with platelet factor 3. Blood. 1965 Nov;26(5):541–553. [PubMed] [Google Scholar]
  17. Rother K., Rother U., Müller-Eberhard H. J., Nilsson J. R. Deficiency of the sixth component of complement in rabbits with an inherited complement defect. J Exp Med. 1966 Oct 1;124(4):773–785. doi: 10.1084/jem.124.4.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rother U., Ballantyne D. L., Jr, Cohen C., Rother K. Allograft rejection in C'6 defective rabbits. J Exp Med. 1967 Oct 1;126(4):565–579. doi: 10.1084/jem.126.4.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. STETSON C. A., Jr Similarities in the mechanisms determining the Arthus and Shwartzman phenomena. J Exp Med. 1951 Oct;94(4):347–358. doi: 10.1084/jem.94.4.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. STETSON C. A., Jr Studies on the mechanism of the Shwartzman phenomenon; certain factors involved in the production of the local hemorrhagic necrosis. J Exp Med. 1951 May;93(5):489–504. doi: 10.1084/jem.93.5.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. STETSON C. A., Jr Studies on the mechanism of the Shwartzman phenomenon; similarities between reactions to endotoxins and certain reactions of bacterial allergy. J Exp Med. 1955 Apr 1;101(4):421–436. doi: 10.1084/jem.101.4.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Skarnes R. C. The inactivation of endotoxin after interaction with certain proteins of normal serum. Ann N Y Acad Sci. 1966 Jun 30;133(2):644–662. doi: 10.1111/j.1749-6632.1966.tb52395.x. [DOI] [PubMed] [Google Scholar]
  23. Snyderman R., Gewurz H., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes. J Exp Med. 1968 Aug 1;128(2):259–275. doi: 10.1084/jem.128.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Taylor F. B., Jr, Müller-Eberhard H. J. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets. J Clin Invest. 1970 Nov;49(11):2068–2085. doi: 10.1172/JCI106425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ward P. A., Cochrane C. G., Muller-Eberhard H. J. Further studies on the chemotactic factor of complement and its formation in vivo. Immunology. 1966 Aug;11(2):141–153. [PMC free article] [PubMed] [Google Scholar]
  26. Zimmerman T. S., Arroyove C. M., Müller-Eberhard H. J. A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6. J Exp Med. 1971 Dec 1;134(6):1591–1600. doi: 10.1084/jem.134.6.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zimmerman T. S., Müller-Eberhard H. J. Blood coagulation initiation by a complement-mediated pathway. J Exp Med. 1971 Dec 1;134(6):1601–1607. doi: 10.1084/jem.134.6.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES